CDKN1B and Alzheimer disease: Further evidence was provided by in vivo studies using LuCaP xenograft tumors in castrated nude mice revealing that AD increased SA β-Gal activity, increased expression of both p27Kip1 and HP1γ and decreased expression of the proliferation marker Ki-67 with minimal apoptosis.